Motilal Oswal Financial Services has issued a buy call for Apollo Hospitals Enterprise, setting a target price of Rs 8,020. They project a 20% EBITDA CAGR and 18% PAT CAGR for the company from FY24 to FY27. This positive outlook is driven by anticipated growth in Healthco's profitability, increased patient capacity, and strong performance in the diagnostics sector.
